Prognostic significance and immune escape implication of tumor-infiltrating neutrophil plasticity in human head and neck squamous cell carcinoma
- PMID: 38358636
- DOI: 10.1007/s13577-024-01024-7
Prognostic significance and immune escape implication of tumor-infiltrating neutrophil plasticity in human head and neck squamous cell carcinoma
Abstract
Tumor-infiltrating neutrophils play a crucial role in the progression of head and neck squamous cell carcinoma (HNSCC). Here, we aimed to statistically quantify the plasticity of HNSCC-infiltrating N2/N1 neutrophils and examine its impacts on survival and immune infiltration landscape. A retrospective study of 80 patients who underwent curative surgical resection for HNSCC between 2014 and 2017 was conducted in this study. HNSCC-infiltrating neutrophil phenotypes were classified using immunofluorescence staining, and the N2/N1 neutrophil plasticity was evaluated via the ratio of N2/N1 neutrophils. We then assessed the correlations between N2/N1 neutrophil plasticity, clinicopathological characteristics, and immune infiltration landscape using rigorous statistical methods. Infiltration variations of N1 and N2 neutrophils were observed between the tumor nest (TN) and tumor stroma (TS), with TN exhibiting higher N2 neutrophil infiltration and lower N1 neutrophil infiltration. High ratios of N2/N1 neutrophils were correlated with advanced TNM stage, large tumor size and invasion of adjacent tissue. High infiltration of N2 neutrophils was associated with decreased overall and relapse-free survival, which were opposite for N1 neutrophils. The independent prognostic role of N2/N1 neutrophil plasticity, particularly within the TN region, was confirmed by multivariate analyses. Moreover, the ratio of N2/N1 neutrophils within the TN region showed correlations with high CD8+ T cells infiltration and low FOXP3+ Tregs infiltration. We identify HNSCC-infiltrating N2/N1 neutrophil plasticity as a crucial prognostic indictor which potentially reflects the tumor microenvironment (TME) and immune escape landscape within HNSCC tissues. Further investigations and validations may provide novel therapeutic strategies for personalized immunomodulation in HNSCC patients.
Keywords: Head and neck squamous cell carcinoma; Immune infiltration landscape; Immunosuppressive microenvironment; Neutrophil plasticity; Prognoses; Tumor-infiltrating neutrophils.
© 2024. The Author(s) under exclusive licence to Japan Human Cell Society.
Similar articles
-
Prognostic value of tumor-associated N1/N2 neutrophil plasticity in patients following radical resection of pancreas ductal adenocarcinoma.J Immunother Cancer. 2022 Dec;10(12):e005798. doi: 10.1136/jitc-2022-005798. J Immunother Cancer. 2022. PMID: 36600557 Free PMC article.
-
Neutrophils in HNSCC Can Be Associated with Both a Worse or Favorable Prognosis.Biomolecules. 2024 Feb 9;14(2):205. doi: 10.3390/biom14020205. Biomolecules. 2024. PMID: 38397442 Free PMC article.
-
Type I conventional dendritic cells and CD8+ T cells predict favorable clinical outcome of head and neck squamous cell carcinoma patients.Front Immunol. 2024 Jun 13;15:1414298. doi: 10.3389/fimmu.2024.1414298. eCollection 2024. Front Immunol. 2024. PMID: 38938577 Free PMC article.
-
The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer-Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy.Cancers (Basel). 2023 Mar 7;15(6):1642. doi: 10.3390/cancers15061642. Cancers (Basel). 2023. PMID: 36980527 Free PMC article. Review.
-
Comprehensive review regarding the association of E2Fs with the prognosis and immune infiltrates in human head and neck squamous cell carcinoma.Asian J Surg. 2024 May;47(5):2106-2121. doi: 10.1016/j.asjsur.2024.01.130. Epub 2024 Feb 5. Asian J Surg. 2024. PMID: 38320907 Review.
References
-
- Marur S, Forastiere AA. Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2016;91(3):386–96. https://doi.org/10.1016/j.mayocp.2015.12.017 . - DOI - PubMed
-
- Chow LQM. Head and neck cancer. N Engl J Med. 2020;382(1):60–72. https://doi.org/10.1056/NEJMra1715715 . - DOI - PubMed
-
- Zhu X, Zhou J, Zhou L, Zhang M, Gao C, Tao L. Association between postoperative radiotherapy for young-onset head and neck cancer and long-term risk of second primary malignancy: a population-based study. J Transl Med. 2022;20(1):405. https://doi.org/10.1186/s12967-022-03544-y . - DOI - PubMed - PMC
-
- Choi JH, Lee BS, Jang JY, Lee YS, Kim HJ, Roh J, et al. Single-cell transcriptome profiling of the stepwise progression of head and neck cancer. Nat Commun. 2023;14(1):1055. https://doi.org/10.1038/s41467-023-36691-x . - DOI - PubMed - PMC
-
- Wang X, Muzaffar J, Kirtane K, Song F, Johnson M, Schell MJ, et al. T cell repertoire in peripheral blood as a potential biomarker for predicting response to concurrent cetuximab and nivolumab in head and neck squamous cell carcinoma. J Immunother Cancer. 2022;10(6): e004512. https://doi.org/10.1136/jitc-2022-004512 . - DOI - PubMed - PMC
MeSH terms
Grants and funding
- SHDC2020CR6011/the Major Clinical Research Project of Shanghai Shen-kang Hospital Clinical Development Center
- SHDC12015114/the Science and Technology Innovation Project of Shanghai Shen-kang Hospital Clinical Development Center
- 81772878/the National Natural Science Foundation of China
- 82003178/the National Natural Science Foundation of China
- shslczdzk00801/the Shanghai Municipal Key Clinical Specialty
LinkOut - more resources
Full Text Sources
Medical
Research Materials